"Why Am I Always Tired?" What the Largest-Ever Genetic Study on Chronic Fatigue Reveals

The world's largest genetic study of ME/CFS reveals 8 genetic signals linked to immune and nervous system dysfunction—finally providing biological answers for millions suffering from unexplained chronic fatigue.

"Why Am I Always Tired?" What the Largest-Ever Genetic Study on Chronic Fatigue Reveals

This article explores breakthrough findings from the DecodeME study, the world's largest genetic investigation into ME/CFS. While this research represents a major scientific advance, it is not medical advice. Always consult healthcare professionals for persistent fatigue symptoms.

The Question Millions Are Asking

Search Reddit for "Why am I always tired?" and you'll find thousands of desperate posts. People describe sleeping 10 hours and waking exhausted. They exercise, eat well, and get normal blood test results—yet simple tasks feel insurmountable. For decades, many have been told their fatigue is "all in their head."

In August 2025, science delivered a powerful response. Researchers at the University of Edinburgh published the initial results of DecodeME—the world's largest genetic study of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Their findings provide the first robust evidence that genetics play a significant role in who develops this devastating condition.¹

The Scale of the DecodeME Study

DecodeME is a genome-wide association study (GWAS) designed to uncover the biological roots of ME/CFS. Unlike smaller studies that left more questions than answers, DecodeME analyzed:

  • 15,579 DNA samples from people with diagnosed ME/CFS
  • 259,909 DNA samples from healthy control subjects
  • All participants of European descent for genetic consistency

The study's methodology is particularly significant because DNA remains unchanged by disease. Any genetic differences found between groups must represent biological causes of ME/CFS, not effects of living with the illness.²

Eight Genetic Signals: The Breakthrough Findings

The DecodeME team identified eight distinct genetic signals where people with ME/CFS differ significantly from the general population. These signals cluster in regions of the genome associated with two critical biological systems: the immune system and the nervous system.¹

At least two of the identified genetic signals relate to the body's ability to fight infections:

OLFM4 codes for a protein called olfactomedin-4 that plays a role in antimicrobial responses. People with specific variants of this gene may have compromised ability to clear bacterial infections.²

ZNFX1 is associated with responses to RNA viruses. This finding aligns with what many ME/CFS patients report: their illness began after what seemed like a routine viral infection.²

FBXL4 emerged as particularly significant. This gene is crucial for keeping mitochondria—the "batteries" inside cells—functioning correctly. The study found FBXL4 is under-expressed in some people with ME/CFS, pointing to potential mitochondrial dysfunction.²

CA10 has been previously linked to chronic pain conditions. Since many ME/CFS patients experience significant pain alongside fatigue, this genetic connection reinforces the neurological aspects of the illness.²

What the Genes Reveal About ME/CFS Biology

Professor Chris Ponting, lead investigator at the University of Edinburgh's Medical Research Council Human Genetics Unit, called the results "a wake-up call" that demonstrates a person's genetics can "tip the balance" on whether they develop ME/CFS.¹

"These provide the first robust evidence for genetic contributions to ME," Ponting stated. "There are many genetic variants that apply across the genome that predispose people to be diagnosed with ME."¹

The genetic signals align remarkably well with how patients describe their illness: infections that never fully resolve, profound fatigue that worsens after activity, and pain that defies conventional explanation.

Critical Findings: What the Study Did NOT Find

Sometimes what a study doesn't find is equally important. DecodeME's negative results challenge long-held assumptions:

The identified genetic signals showed no association with genes related to depression or anxiety. This directly contradicts the psychosomatic theories that have dominated ME/CFS treatment approaches for decades.²

Dr. Beata Godlewska, who studies ME/CFS at the University of Oxford, noted: "It's a very sad fact that people with ME/CFS are still disbelieved and the disease has been so neglected, especially when it comes to research funding. Hopefully this study will come with a benefit of both fighting the stigma, and convincing research funders that this is a truly biological condition."¹

No Explanation for the Gender Gap

ME/CFS diagnoses are approximately four times more common in women than men, yet the DecodeME study found no genetic explanation for this disparity. The research team has yet to analyze the X and Y sex chromosomes, which may hold answers.¹

No Genetic Overlap with Long COVID

With estimates suggesting 67 million people globally have ME/CFS and millions more experiencing long COVID with overlapping symptoms, researchers hoped to find shared genetic factors. The initial DecodeME analysis found no genetic link between ME/CFS and long COVID, though investigators caution that different analytical methods might reveal connections.¹

What Is ME/CFS? Understanding the Condition

Myalgic encephalomyelitis/chronic fatigue syndrome is a complex, chronic medical condition characterized by specific symptom clusters. The 2015 Institute of Medicine diagnostic criteria require three core symptoms plus at least one additional symptom.³

Required Symptoms

1. Substantial reduction in activity: A significant decrease in ability to engage in pre-illness levels of occupational, educational, social, or personal activities that persists for six months or more.

2. Post-exertional malaise (PEM): The hallmark symptom of ME/CFS. Physical or mental exertion triggers a worsening of symptoms that can take days or weeks to recover from. This is not normal tiredness after exercise—it's a crash that can leave patients bedridden.³

3. Unrefreshing sleep: Sleep does not restore energy, regardless of duration or perceived quality.

Additional Symptoms (At Least One Required)

  • Cognitive impairment: Problems with thinking, memory, or concentration often described as "brain fog"
  • Orthostatic intolerance: Worsening of symptoms when standing upright, including dizziness, lightheadedness, or fainting

The Global Impact

ME/CFS represents a massive public health burden:

  • 67 million people affected worldwide¹
  • £3 billion annual economic cost in the UK alone¹
  • No diagnostic test currently exists
  • No cure or FDA-approved treatments specifically for ME/CFS

Patients often spend years seeking diagnosis, visiting multiple specialists while their lives collapse around them. Many are unable to work, maintain relationships, or perform basic daily activities.

From Genetic Discovery to Treatment

The DecodeME findings represent a paradigm shift, but they are just the beginning. The study identified 43 protein-coding genes within the eight signal regions, with 29 appearing especially promising for further investigation.²

Researchers worldwide can now access the DecodeME dataset to conduct targeted studies. The study team specifically invites researchers with expertise in:

  • Immune system biology
  • Nervous system function
  • Mitochondrial disorders
  • Chronic pain mechanisms
  • Viral persistence and clearance

Prof. Anne McArdle, who studies ME/CFS at the University of Liverpool, said the results provide "a solid basis" for future work that could accelerate treatment development.¹

What This Means for People Asking "Why Am I Always Tired?"

If you're experiencing persistent, unexplained fatigue, the DecodeME study offers both validation and guidance:

Validation: For too long, patients with ME/CFS have been dismissed, told their symptoms were psychological, or advised to simply "push through" their fatigue. The genetic evidence proves this is a real biological condition with measurable physical causes.

Guidance: The genetic findings point toward specific biological pathways—immune dysfunction, nervous system abnormalities, and mitochondrial problems. This suggests future treatments will likely target these mechanisms rather than just masking symptoms.

When to Seek Medical Evaluation

While occasional tiredness is normal, certain patterns warrant professional evaluation:

  • Fatigue lasting more than six months
  • Significant reduction in ability to perform normal activities
  • Symptoms that worsen after physical or mental exertion
  • Unrefreshing sleep despite adequate time in bed
  • Cognitive difficulties or "brain fog"
  • Dizziness or worsening symptoms when standing

Important disclaimer: Many conditions can cause chronic fatigue, including thyroid disorders, anemia, sleep apnea, autoimmune diseases, and infections. A thorough medical workup is essential to rule out treatable causes before considering ME/CFS.

The Road Ahead

The DecodeME study has fundamentally changed how we understand chronic fatigue syndrome. By establishing genetic foundations, researchers have:

  1. Validated patient experiences with objective biological evidence
  2. Identified specific biological pathways for targeted research
  3. Dismissed psychosomatic theories that blamed patients for their illness
  4. Created a foundation for diagnostic tests and treatments

As Andy Devereux-Cooke, a DecodeME co-investigator and patient advocate, stated: "The vast majority of the patient population essentially has been abandoned in one way or another, by families, the government, the medical system. This will be huge for the patient population."¹

For millions asking "Why am I always tired?"—the answer is finally coming into focus. It's not in their heads. It's in their DNA.

Sources

  1. Sample, I. (2025, August 6). Scientists find link between genes and ME/chronic fatigue syndrome. The Guardian.
  2. ME Research UK. (2025, August 6). DeCodeME – Initial Results Published.
  3. Centers for Disease Control and Prevention. (2024). IOM 2015 Diagnostic Criteria for ME/CFS.